Close

Spectrum (SPPI) Pops Higher Following Reacquisition of Apaziquone Rights

January 31, 2013 12:43 PM EST Send to a Friend
Spectrum Pharmaceuticals (Nasdaq: SPPI) shares are trading strong the session following a news release earlier of a notable acquisition.

This article: 480 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login